Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
46.22 USD | -1.91% | -12.76% | -23.27% |
Apr. 17 | Scotiabank Upgrades Legend Biotech to Sector Outperform From Sector Perform, Price Target is $65 | MT |
Apr. 17 | Genscript Biotech's Unit Logs $157 Million in Q1 Sales of Blood Cancer Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.27% | 8.57B | |
-2.87% | 102B | |
+2.07% | 96.07B | |
-1.80% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.00% | 13.79B | |
-0.09% | 13.33B | |
+19.26% | 10.94B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- Earnings Flash (LEGN) LEGEND BIOTECH Posts Q3 Loss $-0.43